Varex Imaging CORP

Varex Imaging Corporation successfully refinanced $368 million in senior secured notes with a new $490 million credit facility, expecting over $7 million in annual cash interest savings.

Varex Imaging Corporation announced preliminary first quarter fiscal year 2026 financial results, reporting revenues of $210 million and non-GAAP diluted EPS of $0.19, exceeding guidance expectations.

Varex Imaging Corporation announced robust fourth-quarter and fiscal year 2025 financial results, driven by strong medical and industrial segment performance.

Varex Imaging Corporation announced that Kimberley Honeysett, its Senior Vice President, Chief Legal Officer, and Corporate Secretary, will transition out of her role, remaining as an advisor until December 2027.

Varex Imaging Corporation reported third-quarter fiscal year 2025 revenues of $203 million, exceeding guidance, despite a significant GAAP net loss driven by a goodwill impairment charge.

Varex Imaging Corporation announced a 3% year-over-year revenue increase for Q2 fiscal year 2025, but lowered its short-term outlook due to high tariffs imposed by China.

Varex Imaging Corporation's Q2 filing shows a 1.5% revenue increase to $216.0 million, but a net loss of $8.1 million compared to a profit in the prior year.

Varex Imaging Corporation reported a net income of $2.3 million for Q1 fiscal year 2026, driven by strong Industrial segment revenue growth and improved operating efficiency, despite challenges in the Medical segment.

Varex Imaging Corporation reported a significant net loss for the third fiscal quarter of 2025, primarily driven by a $93.9 million goodwill impairment charge in its Medical segment.

Varex Imaging Corporation reports increased revenue and profitability for the second quarter of fiscal year 2025, while navigating potential impacts from tariffs and trade investigations.

Varex Imaging Corporation reports a revenue increase for the quarter ended January 3, 2025, while addressing ongoing economic and industry challenges.

Varex Imaging Corporation reported a decrease in revenue for the third quarter of 2024, primarily due to lower sales in its Medical segment, while the Industrial segment showed modest growth.

Varex Imaging reported a 4% revenue increase to $844.6 million in fiscal year 2025, but recognized a significant $93.9 million goodwill impairment charge in its Medical segment.

Varex Imaging Corporation's fiscal year 2024 results reflect a decrease in revenue and profit, impacted by global economic instability, supply chain challenges, and geopolitical tensions, particularly in China.

Varex Imaging Corp Director Jay K. Kunkel sold 4,510 shares of common stock for $11.14 per share, executed under a Rule 10b5-1 plan.

Varex Imaging Corp. Director Timothy E. Guertin was granted 12,331 Deferred Stock Units, vesting over one year.

Varex Imaging Corp. Director Jocelyn D. Chertoff was granted 12,331 Deferred Stock Units, aligning interests with shareholders.

Varex Imaging Corp. Director Jocelyn D. Chertoff converted 8,483 Deferred Stock Units into common stock on February 9, 2026.

Varex Imaging Corp. Director Walter M. Rosebrough Jr. converted 10,339 deferred stock units into common stock, increasing his direct beneficial ownership to 52,654 shares.

Varex Imaging Corp. Director Timothy E. Guertin acquired 8,483 shares of common stock through the conversion of deferred stock units.

Varex Imaging Corporation announces its 2026 Annual Meeting of Stockholders to vote on director elections, executive compensation, and auditor ratification.

Varex Imaging Corporation announces its 2026 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, following a fiscal year with revenue growth but increased net loss.

Varex Imaging Corporation amends its proxy statement to clarify the treatment of broker non-votes regarding the approval of an amendment for officer exculpation under Delaware law.

Varex Imaging Corporation will hold its annual stockholder meeting on February 13, 2025, to vote on key proposals including the election of directors, executive compensation, and amendments to the company's certificate of incorporation.

Varex Imaging Corporation will hold its 2025 Annual Meeting of Stockholders virtually on February 13, 2025, to vote on director elections, executive compensation, and other corporate matters.

Vanguard Capital Management has reported beneficial ownership of over 5% of Varex Imaging Corp. common stock as of June 30, 2026.

The Vanguard Group reports 0% beneficial ownership in Varex Imaging Corp following an internal realignment, disaggregating its reporting.

The Vanguard Group reported a 7.20% beneficial ownership stake in Varex Imaging Corp, holding 2,989,847 shares as of September 30, 2025.

Dimensional Fund Advisors LP has filed an amended Schedule 13G, disclosing a 4.8% beneficial ownership stake in Varex Imaging Corp as of September 30, 2025.

Pzena Investment Management LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 10.2% of Varex Imaging Corp's Common Stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.2% in Varex Imaging Corp's common stock as of March 31, 2025.